Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 169

Australia’s mid-caps are fertile territory

The ASX is one of the largest 15 stock markets in the world, with a market capitalisation of $1.5 trillion. What investors might not be aware of, however, is how top-heavy it is. The largest 20 stocks account for 60% of the S&P/ASX300 Index, while financial and mining companies comprise more than two-thirds of the top 20. Banks and miners dominate the local market.

These companies are facing challenging times. Banks are now required to retain more capital on their books, crimping credit growth and putting pressure on returns. At the same time, interest rates are on a downward trend, which has negative impact on their margins. Additionally, they will need to set aside more money in provisions for bad debts, which can only rise from historic lows. All this will cut into their profitability.

Meanwhile, mining companies are being hurt by the decline in commodity prices and a slowdown in the economic growth of China, Australia’s largest trading partner.

Greater investment options

This makes a strong case for investing in the mid- and small-cap companies that comprise the remaining 40% of the ASX and that derives its earnings from more varied sources. This diversity is important, because you don’t want all your stocks exposed to the same growth drivers, nor do you want your returns to be highly correlated.

Once you exclude the top 20 stocks, as the table below demonstrates, the weighting of financial companies falls from 59% to 24%, making it far more balanced and diversified.

Sector breakdown for ASX300 ex-20

If we consider mid-caps alone, they generally have more developed governance and risk frameworks than small companies, their cash flows are more stable and replicable, and their share prices less volatile.

Still, defining what constitutes a mid-cap company is not an exact science. A good starting point is the S&P/ASX Midcap 50 Index, which comprises all stocks listed on the S&P/ASX 100 excluding the top 50 – in other words, numbers 51 to 100. But this is a narrow definition, and fund managers tend to have their own interpretations. At Aberdeen, we think of mid-caps more broadly as future leaders in their sectors with the right foundations to become the next blue chips: it’s more about potential than position in an index.

This potential is reflected in their returns. Over the past five years, the ASX Mid-Cap 50 Index has consistently outperformed the larger ASX100, 200 and 300 ex-20 indexes.

Performance of large cap vs mid cap

Reasons mid-caps may outperform

There are a number of reasons for this.

Firstly, mid-caps have more capacity to grow than blue chips, which are constrained by their size in the sectors they already dominate. Average growth in earnings per share for companies in the S&P/ASX300 ex-20 is forecast to be 14.9% over the next 12 months and 9.4% for the following year, versus 7.05% and 8.9% for the S&P/ASX200 Index, according to Bloomberg data.

Secondly, mid-caps have greater flexibility to disrupt the industries they operate in. For example, NIB Holdings, which offers low-cost health insurance products, is competing against market leaders Bupa and Medibank Private. Its comparative nimbleness and lack of bureaucracy allows it to make quick decisions, enabling it to deliver above-average growth consistently. NIB is also diversifying into new markets.

Thirdly, compared to small companies, mid-caps have greater access to capital to drive their expansion. It means they can gain more exposure to larger and/or faster-growing economies, reducing their dependence on domestic earnings. A good example of this is in the health-care sector. Cochlear, Ramsay Healthcare, ResMed and Fisher & Paykel Healthcare are all mid-caps that derive a strong proportion of their earnings outside Australia.

Cochlear makes implants for the hearing impaired. Initially it focused on infants domestically but has since broken into the market for adults and now sells products in more than 100 countries, becoming a global leader in its field.

Similarly, Fisher & Paykel Healthcare, which designs and manufactures products to treat sleep-disordered breathing conditions, has innovated constantly to extend its range of equipment. In a world of rising obesity levels, it now sells its systems in more than 120 countries.

Be wary of sector titles

As an active manager, the sector a company operates in is not a factor in our investment decision-making. We want to understand if a business can generate returns in excess of its cost of capital. Having said that, we are mindful of avoiding overlapping exposures in our portfolio and we prefer to invest in industries with strong tailwinds.

While we take a company-by-company approach, generally we see industrials as asset-intensive and carrying significant amounts of debt, so we are underweight. Aurizon and Asciano, for example, are leveraged to trading volumes driven by mining and agriculture, creating cash-flow uncertainty.

At the same time, some sector titles are misleading. Consumer discretionary firms, which provide non-essential goods and services such as entertainment and leisure, make up 13% of the ex-20 index. Because they deal in discretionary goods, demand tends to fluctuate. However, Invocare is a mid-cap in this sector that provides funeral services, and we don’t see them as discretionary at all. In a similar vein, wagering and lotteries operator Tatts Group has produced consistent cash flows across investment cycles.

It is this diversity that makes mid-caps such a fertile ground for active managers to find value. They have a wider dispersion of returns than blue chips and offer greater opportunities to uncover mispricing.

These companies don’t have the inherent bias that comes with large index weightings, or the volatility of the smaller end of the market. There’s a lot to like about them. They’re not too big and not too small, just right, as Goldilocks might say.

 

Michelle Lopez is a senior investment manager on the Australian equities team at Aberdeen Standard Investments (formerly Aberdeen Asset Management), including sharing responsibility for the Aberdeen Ex-20 Australian Equities Fund. This article is general information and does not consider the circumstances of any individual.

 

banner

Most viewed in recent weeks

Raising the GST to 15%

Treasurer Jim Chalmers aims to tackle tax reform but faces challenges. Previous reviews struggled due to political sensitivities, highlighting the need for comprehensive and politically feasible change.

7 examples of how the new super tax will be calculated

You've no doubt heard about Division 296. These case studies show what people at various levels above the $3 million threshold might need to pay the ATO, with examples ranging from under $500 to more than $35,000.

The revolt against Baby Boomer wealth

The $3m super tax could be put down to the Government needing money and the wealthy being easy targets. It’s deeper than that though and this looks at the factors behind the policy and why more taxes on the wealthy are coming.

Are franking credits hurting Australia’s economy?

Business investment and per capita GDP have languished over the past decade and the Labor Government is conducting inquiries to find out why. Franking credits should be part of the debate about our stalling economy.

Here's what should replace the $3 million super tax

With Div. 296 looming, is there a smarter way to tax superannuation? This proposes a fairer, income-linked alternative that respects compounding, ensures predictability, and avoids taxing unrealised capital gains. 

The rubbery numbers behind super tax concessions

In selling the super tax, Labor has repeated Treasury claims of there being $50 billion in super tax concessions annually, mostly flowing to high-income earners. This figure is vastly overstated.

Latest Updates

Investment strategies

Trump's US dollar assault is fuelling CBA's rise

Australian-based investors have been perplexed by the steep rise in CBA's share price But it's becoming clear that US funds are buying into our largest bank as a hedge against potential QE and further falls in the US dollar.

Investment strategies

With markets near record highs, here's what you should do with your portfolio

Markets have weathered geopolitical turmoil, hitting near record highs. Investors face tough decisions on valuations, asset concentration, and strategic portfolio rebalancing for risk control and future returns.

Property

Soaring house prices may be locking people into marriages

Soaring house prices are deepening Australia's cost of living crisis - and possibly distorting marriage decisions. New research links unexpected price changes to whether couples separate or silently struggle together.

Investment strategies

Google is facing 'the innovator's dilemma'

Artificial intelligence is forcing Google to rethink search - and its future. As usage shifts and rivals close in, will it adapt in time, or become a cautionary tale of disrupted disruptors?

Investment strategies

Study supports what many suspected about passive investing

The surge in passive investing doesn’t just mirror the market—it shapes it, often amplifying the rise of the largest firms and creating new risks and opportunities. For investors, understanding these effects is essential.

Property

Should we dump stamp duties for land taxes?

Economists have long flagged the idea of swapping property taxes for land taxes for fairness and equity reasons. This looks at why what seems fairer may not deliver the outcomes that we expect.

Investing

Being human means being a bad investor

Many of the behaviours that have made humans such a successful species also make it difficult for us to be good, long-term investors. The key to better decision making is to understand what makes us human and adapt.

Sponsors

Alliances

© 2025 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. To the extent any content is general advice, it has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.